Relationship of Glymphatic Function with Cognitive Impairment, Sleep Disorders, Anxiety and Depression in Patients with Parkinson's Disease
Qian Gui,Jingcai Meng,Mingqiang Shen,Hongxuan Feng,Xiaofeng Dong,Daqiang Xu,Wenxin Zhu,Qingzhang Cheng,Linhui Wang,Guanhui Wu,Yanli Lu
DOI: https://doi.org/10.2147/ndt.s480183
IF: 2.989
2024-09-25
Neuropsychiatric Disease and Treatment
Abstract:Qian Gui, 1, &ast Jingcai Meng, 2, &ast Mingqiang Shen, 1 Hongxuan Feng, 1 Xiaofeng Dong, 1 Daqiang Xu, 3 Wenxin Zhu, 2 Qingzhang Cheng, 1 Linhui Wang, 2 Guanhui Wu, 1 Yanli Lu 3 1 Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), Suzhou, Jiangsu, 215002, People's Republic of China; 2 Department of Physiology and Neurobiology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, 215123, People's Republic of China; 3 Department of Radiology, the Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), Suzhou, Jiangsu, 215002, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yanli Lu, Department of Radiology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), 26 Daoqian Street, Suzhou City, Jiangsu Province, People's Republic of China, Tel +8618251135654, Email Guanhui Wu, Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), 26 Daoqian Street, Suzhou City, Jiangsu Province, People's Republic of China, Email Introduction: Previous studies have predominantly explored the relationship of the glymphatic system with motor symptoms in Parkinson's disease (PD); however, research on non-motor symptoms remains limited. Therefore, this study investigated the association between glymphatic function and non-motor symptoms, including cognitive impairment and sleep disorders, in PD patients. Methods: This study recruited 49 PD patients and 38 healthy controls (HC). Glymphatic function was evaluated using enlarged perivascular spaces (EPVS) in the basal ganglia (BG) region and diffusion tensor image analysis along the perivascular space (DTI-ALPS) index. Cognition, sleep, anxiety, and depression scales were assessed in all participants. According to the scale scores, PD patients were further divided into several groups to identify the presence of non-motor symptoms. Differences in EPVS numbers and ALPS index between PD subgroups and HC group were compared. Spearman correlation analysis was performed to investigate the association between the PD non-motor symptoms and ALPS index. Additionally, receiver operating characteristic (ROC) curves analysis was conducted for ALPS index to predict cognitive impairment and insomnia in PD patients. Results: PD patients with and without non-motor symptoms all showed more EPVS numbers than the controls, and the EPVS numbers in PD patients with cognitive impairment were also greater than those without. Notably, except for the depression subgroup, PD patients with non-motor symptoms showed significantly lower ALPS index than the controls. The Montreal Cognitive Assessment (MoCA) scores were positively correlated, whereas the Parkinson's Disease Sleep Scale (PDSS)-2 and REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) scores were negatively correlated with the ALPS index in PD patients (r=0.3618, P=0.0053; r=− 0.4146, P=0.0015; r=− 0.2655, P=0.0326, respectively). The ALPS index proved to be predictive of cognitive impairment and insomnia in PD patients (AUC=0.7733, P=0.001; AUC=0.7993, P=0.0004, respectively). Conclusion: Glymphatic function is closely associated with cognition and sleep of PD patients. Keywords: glymphatic system, parkinson's disease, non-motor symptoms, cognition, sleep As the population ages, the incidence of Parkinson's disease (PD) continues to rise, making it a highly prevalent neurodegenerative disease. The clinical manifestations of PD encompass motor and non-motor symptoms. Motor symptoms include static tremors, bradykinesia, muscle rigidity, and gait abnormalities, while non-motor symptoms involve sleep disorders, cognitive impairment, anxiety, depression, and hyposmia. 1–5 Although motor symptoms of PD have been extensively investigated, data on non-motor symptoms are limited. However, non-motor symptoms are prevalent among PD patients, often manifesting at any stage of the disease, sometimes even before the onset of motor symptoms. 6 Among these, cognitive impairment, sleep disorders, anxiety, and depression substantially impact patients' quality of life, exacerbating prognosis and placing substantial burdens on both families and society. The pathogenesis of PD primarily involves the misfolding of α-synuclein (a-syn), leading to the formation of Lewy bodies. 7 However, the glymphatic system is involved in clearing metabolic waste and pathogenic proteins such as a-syn and β-amyloid (Aβ) from the brain. 8</sup -Abstract Truncated-
psychiatry,clinical neurology